Oppenheimer raised the firm’s price target on Itron (ITRI) to $133 from $125 and keeps an Outperform rating on the shares. The firm notes shares traded up Tuesday after Itron beat Q4 top/bottom-line consensus estimates and guided FY26 better than feared, while providing multiple indicators for future demand inflection.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ITRI: